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Abstract Diadenosine oligophosphates (ApnA) have been pro-
posed as intracellular and extracellular signaling molecules in
animal cells. The ratio of diadenosine 5P,5R-P1,P3-triphosphate
to diadenosine 5P,5R-P1,P4-tetraphosphate (Ap3A/Ap4A) is
sensitive to the cellular status and alters when cultured cells
undergo differentiation or are treated with interferons. In cells
undergoing apoptosis induced by DNA topoisomerase II inhibitor
VP16, the concentration of Ap3A decreases significantly while
that of Ap4A increases. Here, we have examined the effects of
exogenously added Ap3A and Ap4A on apoptosis and morpho-
logical differentiation. Penetration of ApnA into cells was
achieved by cold shock. Ap4A at 10 WM induced programmed
cell death in human HL60, U937 and Jurkat cells and mouse
VMRO cells and this effect appeared to require Ap4A break-
down as hydrolysis-resistant analogues of Ap4A were inactive.
On its own, Ap3A induced neither apoptosis nor cell differentia-
tion but did display strong synergism with the protein kinase C
activators 12-deoxyphorbol-13-O-phenylacetate and 12-deoxy-
phorbol-13-O-phenylacetate-20-acetate in inducing differentia-
tion of HL60 cells. We propose that Ap4A and Ap3A are
physiological antagonists in determination of the cellular status:
Ap4A induces apoptosis whereas Ap3A is a co-inductor of
differentiation. In both cases, the mechanism of signal transduc-
tion remains unknown.
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1. Introduction
The study of signal transduction pathways has become one
of the most rapidly developing areas of modern molecular cell
biology. Among the most widespread and universal signaling
mechanisms are those which employ the phosphorylation-de-
phosphorylation reactions catalyzed by a variety of protein
kinases and phosphatases (reviewed in [1^6]) and guanine nu-
cleotide binding regulatory proteins (see [7,8]). These and oth-
er pathways are involved in directing the cell toward normal
or malignant proliferation, di¡erentiation or apoptosis. Re-
cently, diadenosine oligophosphates (ApnA) (for review see
[9]) have emerged as putative extra- and intracellular signaling
molecules implicated in the maintenance and regulation of
vital cellular functions and may be considered as a new class
of signal transducers. A wide variety of physiological e¡ects in
bacteria and mammalian cells are associated with alterations
in intracellular ApnA levels, e.g. metabolic responses to heat,
oxidative stress and glucose, and the regulation of prolifera-
tion and the growth cycle, while extracellularly, they act as
neurotransmitters and potent vasoactive agents [10^13]. Re-
cently, we showed that interferons (IFNs) and phorbol ester
12-O-tetradecanoylphorbol-13-acetate (TPA) cause the accu-
mulation of diadenosine 5P,5R-P1,P3-triphosphate (Ap3A), but
not diadenosine 5P,5R-P1,P4-tetraphosphate (Ap4A) in cul-
tured human cells [14]. In contrast, in cells undergoing apop-
tosis induced by the DNA topoisomerase II inhibitor epipo-
dophylotoxin (VP16), the concentration of Ap3A decreased
markedly while the concentration of Ap4A increased [15].
Since TPA-activated and IFN-activated pathways can appa-
rently converge to produce similar long-term e¡ects on cells,
such as growth inhibition, it is possible that di¡erences in
cellular status may be associated with varying intracellular
levels of Ap4A and Ap3A.
The discovery of Ap3A binding and hydrolytic activity of
Fhit, the protein encoded by the putative FHIT tumor sup-
pressor gene [16], has provided insight into the possible func-
tion(s) of Ap3A in vivo. Since Fhit is a close structural ana-
logue of an inhibitor of protein kinase C (PKCI) [17], it is
possible that binding of Ap3A to PKCI may turn o¡ the
kinase inhibitor. It has been suggested that sustained activa-
tion of PKC is necessary for cell di¡erentiation [18]. In order
to determine whether Ap3A and Ap4A can directly in£uence
the cellular status, we have examined the e¡ect of Ap4A on
apoptosis in various permeabilized human and mouse cell
lines. We have also studied the e¡ect of Ap3A on the di¡er-
entiation of HL60 cells in culture.
2. Materials and methods
2.1. Reagents
Ap3A and Ap4A were purchased from Sigma. TPA, 12-deoxyphor-
bol-13-O-phenylacetate-20-acetate (D1), 12-deoxyphorbol-13-O-ace-
tate (D2), 12-deoxyphorbol-13-O-phenylacetate (D3), diacylglycerol
(DAG), 10-oleoyl-2-acetylglycerol (OAG), N-palmitoylsphingosine
(PS) and sapintoxin (ST) were from Calbiochem. [3H]Thymidine
(TdR) (925 TBq/mol) was from Amersham International, VP16 was
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a kind gift from U. Armato, [32P]Ap3A and [32P]Ap4A were kindly
provided by Yu. Skoblov. Diadenosine 5P5R-(P1,P3-di£uoromethy-
lene)-P1,P4-tetraphosphate (AppCF2ppA) and diadenosine 5P,5R-
P1,P4-(P1,P2-methylene-P3,P4-methylene)-tetraphosphate
(ApCH2ppCH2pA) were kindly provided by A. Tshepitsin. Diadeno-
sine 5P,5R-(P1,P2-methylene)-P1,P3-triphosphate (ApCH2ppA) was a
gift from S. Kochetkova. The structure of ApnA analogues was con-
¢rmed by UV, 1H and 31P NMR spectroscopy. All other reagents
were of analytical grade.
2.2. Cell growth and permeabilization
The human promyelocytic leukemia cell line HL60 was grown in
suspension at 37‡C in an atmosphere of 5% CO2 in RPMI 1640
medium supplemented with 10% fetal calf serum. Cells were permea-
bilized by cold shock [19]. Cells in the logarithmic phase were har-
vested by centrifugation at 1000Ug for 10 min at 4‡C, washed once
with PBS, suspended in permeabilizing bu¡er composed of 0.01 M
EDTA, 30 mM 2-mercaptoethanol, 4 mM MgCl2, 0.25 M sucrose and
0.01 M Tris-HCl, pH 7.8, and incubated for 30 min at 4‡C with
ApnA. To reseal, cells were centrifuged, washed twice with PBS and
seeded in complete RPMI medium at 37‡C in an atmosphere of 5%
CO2. Cellular viability was determined by trypan blue exclusion.
2.3. [3H]TdR incorporation into DNA
Aliquots (2 ml) containing 1U106 permeabilized cells and 80 kBq/
ml of [3H]TdR were incubated for 2 h at 37‡C, centrifuged, then 2 ml
of ice-cold trichloroacetic acid (TCA) was added to the pellet and
shaken vigorously. The samples were ¢ltered through Whatman GF/
C glass ¢lters, washed ¢ve times with 5% TCA and once with ethanol.
The ¢lters were dried and counted in a toluene scintillation £uid. For
radioautography, [3H]TdR (925 TBq/mol, 29.6 kBq/ml) was added to
the culture medium immediately after cold shock. After 24 h, the cells
were ¢xed using ice-cold ethanol and acetic acid (3:1 v/v). The cell
preparations were washed with water, covered with photographic
emulsion, exposed for 3 days, then developed and stained with Giem-
sa stain (Merck). The percentage of 3H-labelled cell nuclei was deter-
mined microscopically.
2.4. Analysis of DNA and cell morphology
The HL60 cells were subjected to cold shock in the presence of
Ap4A for 30 min at 4‡C as described above, centrifuged, washed
with PBS and seeded in six well plates in complete RPMI 1640 me-
dium. For examination of morphology, the cells were washed twice
with cold serum-free RPMI 1640 and cell smears were prepared and
stained with 1 Wg/ml of Hoechst 33258 (Sigma) in PBS, embedded in
glycerol. Morphological assessment was performed with a Leitz £uo-
rescent microscope (U60 objective). The type of cell death in Ap4A-
treated cells was determined based on morphological features charac-
teristic of apoptosis (cell shrinkage, nuclear condensation and exten-
sive formation of membrane blebs and apoptotic bodies). DNA was
extracted 8 h after cell seeding using a DNA puri¢cation kit (Fermen-
tas). Electrophoresis was carried out on a 1% agarose gel containing
0.5 Wg/ml ethidium bromide.
2.5. Cell di¡erentiation
2U105 cells were cold-shocked in the presence of ApnA, centri-
fuged, washed with PBS and seeded in 24 well plates in complete
RPMI 1640 medium and grown under 5% CO2 for 48 h at 37‡C in
the presence of PKC activators, TPA, OAG, PS, ST, D1, D2 or D3.
The di¡erentiated cells exhibited intense adherence to the plastic dish
with prominent pseudopodia formation. To follow cell di¡erentiation,
cells were washed with cold RPMI 1640, cell smears were prepared
and stained with nitroblue tetrazolium. The percentage of positive
cells was counted.
3. Results
3.1. Cell permeabilization
The primary source of intracellular ApnA is synthesis in the
cytoplasm by aminoacyl-tRNA synthetases [9,10]. To change
intracellular ApnA experimentally, cells were permeabilized by
cold shock [19] in the presence of ApnA. Cold-shocked HL60
cells were morphologically intact and more than 95% of the
treated cells remained viable as revealed by trypan blue ex-
clusion. Uptake of Ap3A was monitored with 32P-labelled or
£uorescently labelled Ap3A. The Ap3A £uorescence was
evenly distributed in the cell population and located mostly
in the cytosol. Uptake of Ap3A at di¡erent concentrations in
the cold shock bu¡er was studied. Routinely, we used cold
shock bu¡er with 10 WM Ap3A which corresponded to an
intracellular concentration of 0.36 WM.
3.2. DNA synthesis in permeabilized cells
Permeabilized cells retain their ability to actively incorpo-
rate [3H]TdR into DNA after a short lag period of 1 h (Fig.
1). This DNA synthetic ability was only slightly reduced
(8 þ 3%) by the presence of 10 WM Ap4A in the cold shock
bu¡er. Addition of 10 WM Ap3A or a non-hydrolyzable ana-
logue of Ap3A, ApCH2ppA, resulted in a more signi¢cant
inhibition of DNA synthesis (24 þ 3% and 26 þ 3%, respec-
tively). We also followed [3H]TdR incorporation into DNA
of ApnA-treated cells by autoradiography of ¢xed cells on
emulsion-covered slides. The number of cells actively synthe-
sizing DNA 24 h after cold shock with 10 WM Ap3A did not
change signi¢cantly compared to control permeabilized cells.
Addition of ApCH2ppA resulted in a slight (7 þ 2%) decrease
in the number of cells actively synthesizing DNA.
3.3. Ap4A-induced apoptosis in di¡erent mammalian cell lines
In the HL60 cells permeabilized in the presence of Ap4A,
the appearance of cytoarchitectural features typical of pro-
grammed cell death were observed (Fig. 2A). The proportion
of apoptotic cells reached 24 þ 2% of the total cell number
after incubation for 24 h with Ap4A. The number of cells in
the S-phase was 18 þ 2%. DNA extracted from permeabilized
HL60 cells treated with Ap4A under cold shock conditions
showed a characteristic fragment size distribution after agar-
ose gel electrophoresis. DNA fragments of about 200 bp ap-
peared after 8 h of incubation with Ap4A (Fig. 2B). Ap4A
also induced apoptotic DNA fragmentation in human U937
monocytes, human Jurkat T-cells and in mouse adenocarcino-
ma VMRO cells but not in human H299 lung cancer cells,
human teratocarcinoma NT2 cells or mouse Swiss 3T3 ¢bro-
blasts (Table 1). Interestingly, the hydrolysis-resistant Ap4A
analogues AppCF2ppA and ApCH2ppCH2pA failed to in-
duce apoptosis in any of the cell lines tested (e.g. Fig. 3),
Fig. 1. DNA synthesis in permeabilized HL60 cells in the presence
of ApnA. DNA synthesis was measured by [3H]TdR incorporation
into DNA as described in Section 2.
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suggesting that hydrolysis of Ap4A by its intracellular target
may be required for its action.
3.4. ApnA and cell di¡erentiation
The HL60 cells cold-shocked in the presence of 1 or 10 WM
Ap3A yielded a few cells with a slightly altered morphology
and occasional apoptotic cells. However, no typical macro-
phage-like di¡erentiated cells were observed after 48 h of in-
cubation in complete RPMI 1640 medium. No changes were
observed using the hydrolysis-resistant Ap3A analogue
AppCH2pA either. Next, we tested known di¡erentiation-in-
ducing agents such as PKC-activating compounds for their
potential ability to cooperate with Ap3A in inducing di¡er-
entiation of HL60 cells into macrophage-like cells (Table 2).
When cells were treated with 10 WM Ap3A in combination
with PKC activators D1 or D3 at 20 nM, a concentration
which by itself did not induce di¡erentiation (Table 2),
24 þ 2% and 20 þ 2% of the cells, respectively, di¡erentiated
into macrophage-like cells after 48 h of incubation in com-
plete RPMI 1640 medium (Fig. 4). The PKC activators OAG,
PS, ST and D2 were unable to cooperate with Ap3A in in-
duction of di¡erentiation. Consequently, Ap3A manifests a
synergistic e¡ect with certain PKC activators in the di¡eren-
tiation of HL60 cells.
4. Discussion
A variety of conditions and agents have been identi¢ed
Table 1
Ap4A e¡ect on induction of apoptotic DNA fragmentation in mam-
malian cells
Cells Ap4A, WM Induction of DNA
fragmentationa
HL60 1 +
10 +
U937 1 +
10 +
Jurkat 1 +
10 +
H299 1 3
10 3
50 3
NT2 1 3
10 3
50 3
VMRO 1 +
10 +
Swiss 3T3 1 3
10 3
(+), DNA ladder typical for apoptosis; (3), no DNA fragmenta-
tion.
aDNA was isolated from human and mouse cells after 18 h of incu-
bation with Ap4A.
Fig. 3. Induction of apoptosis by hydrolysis-resistant Ap4A ana-
logues in mouse adenocarcinoma VMRO cells. A: DNA from con-
trol cells. DNA was extracted from the cells and electrophoresed in
a 1% agarose gel. Lane 1, DNA from non-permeabilized cells
treated with Ap4A; lane 2, DNA from permeabilized cells ; lane 3,
DNA from cells permeabilized in the presence of Ap4A. B: E¡ect
of Ap4A analogues on the induction of apoptosis in VMRO cells.
Lane 1, 1 WM AppCF2ppA; lane 2, 10 WM AppCF2ppA; lane 3,
1 WM ApCH2ppCH2pA; lane 4, 10 WM ApCH2ppCH2pA; lane 5,
DNA from V Hind digest.
Fig. 2. ApnA-induced apoptosis in HL60 cells. A: Apoptotic morphology of HL60 cells treated with 10 WM Ap4A. The formation of mem-
brane blebs and apoptotic bodies is visible 24 h after treatment. B: Apoptotic DNA degradation in cold-shocked cells. DNA was extracted
from the cells 8 h after treatment with VP16 or ApnA and electrophoresed in a 1% agarose gel. Lane 1, no additions; lane 2, 20 Wg/ml of
VP16; lane 3, 1 WM Ap4A; lane 4, 10 WM Ap4A; lane 5, 10 WM Ap3A.
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during the last decade as inducers of programmed cell death
or di¡erentiation (for reviews see [20^24]). To this list can now
diadenosine oligophosphates be added. Previously, we ob-
served that the intracellular concentration of Ap3A and
Ap4A in cultured cells undergoing apoptosis changed in op-
posite directions: the level of Ap4A became elevated whereas
the level of Ap3A diminished [15]. We suggested that apopto-
sis may be intimately associated with elevated levels of Ap4A
or an increased Ap4A/Ap3A ratio. Here, we have con¢rmed
that in cells made permeable to Ap4A, an increase in intra-
cellular concentration of Ap4A induces a large proportion of
cells (about one quarter of the total number) to undergo
apoptosis. This e¡ect of Ap4A is speci¢c since (i) Ap3A, a
close analogue of Ap4A, failed to induce apoptosis (Fig. 2)
in agreement with our earlier observation showing that Ap3A
decreases in apoptotic cells [15] and (ii) hydrolysis-resistant
analogues of Ap4A were also inactive as apoptotic inducers.
A further speci¢c aspect of the action of Ap4A is the sensi-
tivity of only certain cell types.
The inability of two di¡erent Ap4A analogues to induce
apoptosis is interesting given their structures and sensitivities
to hydrolysis. The isosteric ApCH2ppCH2pA is highly resist-
ant to asymmetrical hydrolysis by the eukaryotic Ap4A hy-
drolase but is recognized by this enzyme as a competitive
inhibitor, suggesting a structure similar to Ap4A [25]. It is
also totally resistant to symmetrical hydrolysis [25]. Thus, its
inability to induce apoptosis may indicate that hydrolysis of
Ap4A is required for manifestation of its activity. The isopo-
lar AppCF2ppA is an excellent substrate for the eukaryotic
Ap4A hydrolase but strongly resists symmetrical hydrolysis
[25]. Hence, the combined ine¡ectiveness of these analogues
implies that symmetrical hydrolysis by their intracellular tar-
get may be an essential factor in the mode of action of Ap4A.
What might this target be? It was suggested some years ago
that the Ap4A binding protein associated with DNA polymer-
ase-K possessed a symmetrical Ap4A hydrolyzing activity [26].
If DNA polymerase-K is the target, Ap4A would provide an-
other intriguing connection between apoptosis and the proc-
esses of DNA replication, repair and the cell cycle, with which
DNA polymerase-K is intimately linked [27].
An alternative target for apoptotic action of Ap4A might be
the Fhit Ap3A hydrolase, which also binds and hydrolyzes
Ap4A [28]. However, in this case, Ap3A might be expected
to behave similarly to Ap4A but from our data, this seems not
to be the case (Fig. 2). Also, although the ability of
AppCF2ppA and ApCH2ppCH2pA to be recognized or hy-
drolyzed by the Fhit hydrolase has not been measured di-
rectly, mechanistic studies of the Fhit reaction would suggest
that AppCF2ppA should be an as e¡ective substrate for Fhit
as Ap4A [29]. Clearly, further studies are required to de¢ne
the genuine target more precisely for the apoptotic action of
Ap4A.
Fig. 4. Adherence of HL60 cells induced by PKC activator D1 in combination with Ap3A. Cells were incubated for 48 h in complete RPMI
1640 medium after cold shock. A: No additions. Cell di¡erentiation was not observed in the presence of Ap3A or D1 added separately and the
picture was identical to that shown here. B: 10 WM Ap3A+20 nM D1. Di¡erentiated HL60 cells are clumped and adhere to the bottom of the
£ask. Similar results were obtained with 20 nM D3+10 WM Ap3A.
Table 2
Cooperation between Ap3A and PKC activators in di¡erentiation of
HL60 cells
Drugs Concentration, M Adherence
Without Ap3A With Ap3A
TPA 1.3U1038 +a +
6U1039 + +
1.3U1039 + +
OAG 2U1035-b 3b 3
5U1035 3 3
1U1034 3 3
PS 2U1036 3 3
2U1035 3 3
1U1034 3 3
ST 1.2U1038 + +
1.2U1039 3 3
D1 2U1038 3 +
2U1036 + +
D2 2.5U1038 3 3
2.5U1039 3 3
D3 2.2U1038 3 +
2.2U1037 + +
a(+), more than 10% of the cells were di¡erentiated.
b(3), no di¡erentiated cells were found.
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Our main conclusion that Ap4A is associated with the in-
duction of apoptosis in certain cell types is consistent with a
number of earlier observations. The action of apoptosis-in-
ducing agents, such as Q-irradiation, bleomycin and other
DNA damaging treatments that cause the accumulation of
strand breaks, is accompanied by an increase in the intracel-
lular levels of Ap4A [30,31]. Other agents known to cause an
increase in the percentage of apoptotic cells, such as ethanol,
arsenite, cadmium and heat shock, are also accompanied by
an elevation in the level of Ap4A [31].
It is known that many apoptosis-inducing agents block cell
proliferation at the G1/G0 phase (reviewed in [32^34]). The
G1 arrest is required for DNA repair [35]. To distinguish
whether Ap4A may be involved in cell cycle arrest or in apop-
totic DNA cleavage, we studied the e¡ect of Ap4A on thymi-
dine incorporation into DNA. The DNA-synthesizing activity
of cells permeabilized in the presence of Ap4A was slightly
reduced (8^10%) when [3H]TdR incorporation was measured
by TCA precipitation. However, when the percentage of 3H-
labelled cell nuclei was determined microscopically, the num-
ber of Ap4A-treated cells actively synthesizing DNA was
found to have diminished by 18^20% compared to control
cells (43%), suggesting that the principal e¡ect of Ap4A is
probably on cell cycle arrest.
Recently, it was shown in Escherichia coli that Ap4A can
act as a signal coupling DNA replication and initiation of cell
division. The elevation of the Ap4A concentration induces cell
division and produces many small cells, each with a single
nucleoid [36]. If the same was true in mammalian cells,
then, the apoptotic-inducing activity of Ap4A may somehow
be related to uncoupling of the timing of mitotic activation
and completion of DNA replication (‘aberrant mitosis’).
In addition to physiological regulators of cell death, many
environmental stresses also cause apoptosis and an elevation
of Ap4A [31,37]. Recent studies have implicated stress-acti-
vated protein kinases (SAPKs) in the response to environmen-
tal stress [38]. SAPKs induce apoptosis via the phosphoryla-
tion of factors regulating transcription (c-Jun, Elk-1, ATF-2)
[39] as well as by direct or indirect activation of the caspase
cascade [40]. Since activation of SAPKs is frequently observed
in apoptotic cells, cooperation may occur between Ap4A and
SAPKs.
Since the level of Ap3A increases during di¡erentiation [15],
we tested Ap3A for its potential ability to cooperate with
other di¡erentiation-inducing agents. TPA, a well-known in-
ducer of HL60 myeloid cell di¡erentiation to macrophage-
like, exerts many of its e¡ects through PKC activation [41].
We have screened a number of PKC-activating compounds in
order to induce HL60 di¡erentiation in combination with
Ap3A (Table 2). When cells were treated with D1 of D3 to-
gether with Ap3A, 20^22% of cells were di¡erentiated into
macrophages (Fig. 4). No cell di¡erentiation was induced by
either Ap3A alone or D1/D3 alone at the concentrations used.
Consequently, Ap3A manifests a synergistic e¡ect with some
PKC activators. The activation of PKC by TPA or its ana-
logues results in the phosphorylation of speci¢c substrate pro-
teins. Some observations suggest, however, that activation of
PKC cannot by itself account for this macrophage-like di¡er-
entiation [42]. For example, OAG binds to and activates PKC
and induces the rapid phosphorylation of HL60 cellular pro-
teins but does not induce HL60 di¡erentiation [43]. An e¡ect
of TPA other than or in addition to activation of PKC might
account for the macrophage-like di¡erentiation of HL60
[44].
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